5-Alpha Reductase Inhibitors
Impact of 5-Alpha Reductase Inhibitors Treatment for Benign Prostatic Hyperplasia on Erectile Dysfunction: A Meta-Analysis
... of 5-alpha reductase inhibitors treatment for BPH on erectile ...about 5-alpha reductase inhibitors therapy in BPH was performed among PubMed, EMBASE, Science ...
6
Pre Androgen Ablation Prostate Cancer Patients Who Bleed Do Well with 5 Alpha Reductase Inhibitors
... that 5 alpha reductase inhibitors prevent the conversion of testos- terone to dihydrotestosterone ...2, 5-alpha reductase inhibitor has been found to re- duce ...
9
A Review on Finasteride: A 5-Alpha Reductase Inhibitors, its Mechanism, Facts and Benefits
... potential.5-alpha reductase inhibitors, such as finasteride and dutasteride, are becoming more commonly prescribed for women with hair ...and 5 mg ...
5
INDIAN HERBS THAT ACT AS 5-ALPHA REDUCTASE INHIBITORS
... 5AR inhibitors, these are the enzymes responsible for converting testosterone to dihydrotestosterone (DHT), which is important for the progression of benign prostatic ...
9
The role of 5 alpha reductase inhibitors in prostate pathophysiology: Is there an additional advantage to inhibition of type 1 isoenzyme?
... by 5-alpha reductase (5-AR) enzymes types 1 and ...cancer. Inhibitors of 5-AR such as dutasteride and finasteride may therefore have an important role in the prevention and ...
6
Pharmacophore and Atom Based 3D QSAR Studies on the Novel 5-Alpha-Reductase Inhibitors
... Undertaken research work intended to throw light on the three-dimensional structural properties of inhibitors of 5aR. The Phase module was used to carry out the pharmacophore modeling and QSAR studies of ...
7
Stabilization of Prostate Cancer with Amanita phalloides : Intervals with 5-Alpha-Reductase Inhibitors and Melatonin to Circumvent Resistance: Case Report Isolde Riede 1*
... In 1991 intestinal polyps (adenoma) were removed. In 1997 a cyst (adenoma) of the left kidney was removed. In 1999 two additional adenomas were removed. In 2002 an additional adenoma was removed. The physical examination ...
6
Role of 5 alpha-reductase inhibitors in the management of prostate cancer
... patient. 5 alpha- reductase (5AR) inhibitors have a dramatic effect on benign prostatic disease with low ...5AR inhibitors in the prevention and treatment of prostate ...5AR ...
8
Risk of gynecomastia and breast cancer associated with the use of 5-alpha reductase inhibitors for benign prostatic hyperplasia
... To date, there have been no large observational studies of real-world data that evaluate the association between the use of 5ARIs and the risk of gynecomastia. In addition, clinical trials are neither large enough nor ...
9
PIC50PRED: A PIC50 PREDICTION TOOL FOR 5 ALPHA REDUCTASE ENZYME
... Quantitative structure-activity relationship (QSAR) is a reliable in silico technique developed to model the biological activity based on the chemical structure [5-7]. The biological activity of the candidate drug ...
5
Oxidative stress in prostate hyperplasia and carcinogenesis
... acid; 5-ARIs, 5 α -Reductase inhibitors; 5-ARIs, 5 α -reductase inhibitors; 8-EPI, 8-isoprostanes; 8-OHdG, 8-hydroxy-2'-deoxyguanosine; ADT, Androgen deprivation ...
19
Effect of prostatic inflammation on the outcome of patients with benign prostatic hyperplasia treated by transurethral resection of the prostate
... ABBREVIATIONS 5-ARI: Five alpha reductase inhibitor AIP: Asymptomatic inflammatory prostatitis BPH: Benign prostatic hyperplasia COAD: Chronic obstructive airway disease CPPS: Chronic pr[r] ...
48
Design, synthesis, toxicity estimation and molecular docking studies of N-(Furan-2-yl)-1-(5-substituted) phenyl-1,3,4-oxadiazol-2-yl) methanimine as antitubercular agents
... The design of newly synthesized N-(furan-2-yl) -1-(5-substituted) phenyl-1,3,4-oxadiazol-2-yl) methanimines as enoyl ACP-reductase inhibitor was based up on the similarity based structural features of known ...
6
<p>Integrative and Analytical Review of the 5-Alpha-Reductase Type 2 Deficiency Worldwide</p>
... by 5 α -reductase enzyme. 2 The 5 α -reductase type 2 de fi ciency syndrome was biochemically and clinically reported in 24 individuals from Dominican Republic and two siblings from North ...
14
A STUDY ON DIHYDROFOLATE REDUCTASE AND ITS INHIBITORS: A REVIEW
... INTRODUCTION: Sidney Futterman fractionated a chicken liver extract and obtained a preparation that catalyzed the reduction of both folate and DHF to THF in 1944. He also found that Methotrexate and Aminopterin, another ...
13
Pleiotropic effects of the HMG-CoA reductase inhibitors
... Abstract: The HMG-CoA reductase inhibitors (statins) are used extensively in the treatment of hyperlipidemia. They have also demonstrated a benefit in a variety of other disease processes. These secondary ...
11
<p>The clinical significance of statins-macrolides interaction: comprehensive review of in vivo studies, case reports, and population studies</p>
... Membrane transporters can either facilitate the uptake of their substrates into cells (in fl ux) or facilitate the excretion of their substrates out of cells (ef fl ux). Human OATPs are a membrane in fl ux transporter ...
16
NEW INSIGHTS INTO MOLECULAR TARGETS FOR DEPRESSION
... reuptake inhibitors, dopamine agonists, targeting GABA) and beyond monoaminergic strategies including corticotropin-releasing factor (CRF)-1 receptor antagonists, Inhibition of glucocorticoid function, substance P ...
7
Design, development, drug-likeness, and molecular docking studies of novel piperidin-4-imine derivatives as antitubercular agents
... (EACP) reductase enzyme (code 1ZID, Protein Data Bank), which represents a good prediction of the interactions between the molecules and EACP reductase with minimum binding ...
9
Induction of a deficiency of steroid delta 4 5 alpha reductase activity in liver by a porphyrinogenic drug
... phenobarbital on drug oxidation and steroid 5alpha-reduction in man were examined to determine if this drug could produce changes in steroid 5alpha-reductase activity which mimicked those seen in patients with ...
7